Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mineralys Therapeutics (MLYS) EPS (Basic) (2022 - 2026)

Quarterly results put EPS (Basic) at -$0.47 for Q1 2026, up 40.51% from a year ago — trailing twelve months through Mar 2026 was -$2.0 (up 46.38% YoY), and the annual figure for FY2025 was -$2.29, up 37.43%.

Mineralys Therapeutics has reported EPS (Basic) over the past 5 years, most recently at -$0.47 for Q1 2026.

  • EPS (Basic) reached -$0.47 in Q1 2026 per MLYS's latest filing, down from -$0.35 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.31 in Q2 2023 and bottomed at -$1.75 in Q4 2022.
  • Median EPS (Basic) over the past 5 years was -$0.7 (2024), compared with a mean of -$0.84.
  • The largest annual shift saw EPS (Basic) surged 75.4% in 2023 before it plummeted 167.74% in 2024.
  • Over 5 years, EPS (Basic) stood at -$1.75 in 2022, then surged by 64.0% to -$0.63 in 2023, then plummeted by 55.56% to -$0.98 in 2024, then surged by 64.29% to -$0.35 in 2025, then tumbled by 34.29% to -$0.47 in 2026.
  • Business Quant data shows EPS (Basic) for MLYS at -$0.47 in Q1 2026, -$0.35 in Q4 2025, and -$0.52 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 3.06
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 0.00
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 0.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 4.06
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 6.99
8 Evaxion A 65.12 Bn 65.10 Bn - 0.00
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 1.55
10 Mineralys Therapeutics 2.50 Bn 2.50 Bn - -0.47

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.47
Dec 31, 2025 -0.35
Sep 30, 2025 -0.52
Jun 30, 2025 -0.66
Mar 31, 2025 -0.79
Dec 31, 2024 -0.98
Sep 30, 2024 -1.13
Jun 30, 2024 -0.83
Mar 31, 2024 -0.70
Dec 31, 2023 -0.63
Sep 30, 2023 -0.57
Jun 30, 2023 -0.31
Mar 31, 2023 -0.51
Dec 31, 2022 -1.75
Sep 30, 2022 -1.29
Jun 30, 2022 -1.26
Mar 31, 2022 -1.48